AM-816

N/A

Report date: 2024/05/08 10:31:19

Base Information

Drug NameAM-816
Drug Alias NameNimvec™ AM 816AM-816
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmarna Therapeutics BV
China Registration ClassN/A

Develop Information

Active CompaniesAmarna Therapeutics BV
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A